Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Schiller
Ampronix

Focused Ultrasound Technology Improves Myocardial Remodeling after Heart Attack

By Medimaging International staff writers
Posted on 05 Mar 2013
German scientists have revealed encouraging findings that allows the morphologic and functional sequelae of a myocardial infarction to be reduced. Tiny gas bubbles are forced to oscillate within the heart using focused ultrasound, which improves microcirculation and decreases the size of the scar tissue. Following myocardial infarction, the findings revealed that the lab mice have improved cardiac output using this technology, as compared to untreated animals.

The study’s findings were published online February 25, 2013, in the journal PLOS ONE. In Germany, about 280,000 people suffer a myocardial infarction per year; more than 52,000 die as a result. Due to an occluded vessel, parts of the heart muscle no longer have sufficient circulation and the tissue dies off. These areas are not replaced by new heart muscle cells but instead by scar tissue—this typically causes the pump function of the heart to decrease after a heart attack. Scientists from the Bonn University Hospital the Bonn University Hospital Bonn University Hospital (Germany) have tested the technology on mice with which scar tissue can be reduced and cardiac output increased.

“There are attempts to treat the scar tissue with gene therapy or stem cells—by contrast, we have chosen a physical approach to treatment,” reported adjunct professor Dr. med. Alexander Ghanem, from the department of cardiology of the Bonn University Hospital Bonn University Hospital. The researchers injected a total of 17 mice that had earlier had a myocardial infarction with microscopically small, gas-filled bubbles in the bloodstream. Once the microbubbles reached the heart, they were made to vibrate there using focused ultrasound. “Through this mechanical stimulation, the circulation of the area of the infarction is improved—and the scar shrinks,” Dr. Ghanem noted.

The scientists compared the findings of the mice treated with the microbubbles to those of a control group. Two weeks after the myocardial infarction, there was predicted worsening of heart function in the control group due to the maturing of the scar tissue. In contrast, the mice treated with the microbubbles did not develop any cardiac insufficiency. Jonas Dörner, the first author of the study, summarized the results, “The pumping function was significantly better in the treated animals as compared to the control group; there was also a significantly smaller amount of decayed heart muscle tissue.”

The scientists searched for the causes of these promising results, which, however, up to now, are unclear. Following ultrasound treatment of the mice, it was shown that the amount of the body’s own growth hormones significantly increased in the heart. “This is evidently the reason why the scar formation decreased as a result of the oscillating microbubbles,” said Dr. Ghanem. The scientists now hope that humans will also be able to ultimately be treated with the microbubble-ultrasound technique; however, additional study is still needed. “Potentially, all patients who have had an acute myocardial infarction are eligible for this follow-up treatment.” explained Dr. Ghanem. Microbubbles are already used as a contrast imaging agent.

The study, conducted with support from the BONFOR funding program of the Medical Faculty of Bonn University and the German Heart Foundation [Deutsche Herzstiftung e.V.], gave rise to a patent application. “Together with the company Philips Medical [Best, The Netherlands], we developed a novel ultrasonic probe which enables a standardized impulse discharge in the heart,” Dr. Ghanem stated.

The two ultrasound sources linked together are contained in one hybrid ultrasonic probe: one with low frequency for the focused stimulation of the microbubbles in the target organ and one with higher frequency for imaging. In this manner, it can be very precisely determined where the scar tissue and the microbubbles are located. “This study demonstrates again that university research inspires technological developments in medicine,” stated Dr. Ghanem.

Related Links:
Bonn University Hospital
Philips Healthcare


Channels

Radiography

view channel
Image: Agfa HealthCare’s DX-D Mobile Retrofit solution will allow hospitals an easy and affordable way to upgrade existing GE Healthcare’s AMX 4 and 4 plus mobile X-ray systems to direct radiography (DR) (Photo courtesy of Agfa Healthcare).

Retrofit Enables Cost-Effective Upgrade of Existing Mobile X-Ray Systems to Direct Radiography

A mobile retrofit system has been designed to be mounted on mobile X-ray systems to create an easy way for hospitals to go digital without having to replace existing mobile X-ray units. A direct radiography... Read more

MRI

view channel
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).

Diffusion-Weighted MRI Becoming Major Tool to Diagnose Patients with Transient Ischemic Attacks

With the development of brain imaging, including cranial computed tomography (CCT), and particularly diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI), the diagnosis of transient ischemic... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.